The CEO at Invisio has launched multiple CNS products internationally with a particular focus on Europe.

Invisio is targeting products that can be launched in the UK, Europe and RoW through mutual recognition or other expediated centralized regulatory processing such as that available to the EMA.

Invisio is currently actively seeking new products, please send your non-confidential information to:

rp@invisiopharm.com